Research
VISTAS Itch Trial – Entry Age Now 16 Years
The age for entry onto this trial investigating a drug for itch has changed from 18 years to 16 years.
Read MoreQuality of Your PSC Care
ERN RARE-LIVER survey results have been published. Thank you to the 939 people with PSC who took part in this survey.
Read MoreNEW CLINICAL TRIAL FOR ITCH CALLED PACIFIC
New clinical trial testing a drug for itch – recruiting now
Read MoreLaunching Mission 2030
Mission 2030 – help us find a breakthrough in PSC research
Read More2023 Research Grants Available
Research funding opportunities available now.
Read MoreTake part in the DYNAMHIX Study
The DYNAMHIX study is recruiting volunteers to take part at the John Radcliffe Hospital Oxford.
Read MoreA Step Closer to a PSC Blood Test
Update from Dr Rushbrook and Dr Goode
Read MoreStudy to Investigate Brodalumab in the Treatment of PSC
Study to Investigate Brodalumab in the Treatment of Primary Sclerosing Cholangitis
Read More£5.6 Million Award for Clinical Trial to Reduce Risk of Cancer in People with PSC
£5million landmark study called ASP-PSC to investigate the effect of taking aspirin on reducing cancer in people with PSC.
Read MoreNew European Guidelines for the care of People with PSC
A summary of the latest PSC care guidelines for Europe.
Read More